For Immediate Release
Chicago, IL –August 23, 2017 - Stocks in this week’s article includeGlu Mobile (NASDAQ:GLUU – Free Report), Calumet Specialty Products Partners (NASDAQ:CLMT – Free Report), The Bancorp (NASDAQ:TBBK – Free Report), Immunomedics (NASDAQ:IMMU – Free Report) and Hudbay Minerals (NYSE:HBM – Free Report).
By Kevin Matras
Explosive Stocks Under $10
This screen is a bit of a departure from my normal stock screens.
Usually I require my screens to have a minimum price of $10 per share.
But I do at times scan for stocks under $10. And that's one of the screens I'm running for myself right now.
One dollar is a common threshold when screening for stocks. A lot of investors actively avoid penny stocks due to the speculative nature, the often wide bid/ask spreads, and the excessive volatility that is all too common in stocks under $1.00.
But some, of course, work out spectacularly well. And that's probably what keeps people interested in them.
Seeing a stock make a 100% return or 200% return or more from a base of 50 cents, for example, seems easier than investing in a $50 stock or $100 stock and seeing that double or triple.
Five dollars is another common minimum when screening for stocks since many institutional investors won't even consider a stock if it's trading under $5. And since institutional investors are usually the ones that can move a stock; having stocks that are open to them is usually a bonus.
And quite frankly, lots of cheap stocks are cheap for a reason, i.e., that's all they're worth.
But being over $5 does put them into a different category of consideration. Maybe not the best category, but a step up from stocks less than a dollar.
Stocks Under $10
My minimum has typically been $10. With over 10,000 stocks out there, this minimum quickly lets me cull down several thousand stocks with a click of a button.
That doesn't mean there aren't any good stocks below that price point, because there are.
And I can recall several sub-$10 stocks in the past that worked out exceptionally well. Maybe it's because I use them sparingly. Or maybe it's because I'm ultra picky in selecting them.
Either way, there can be a place for cheaper stocks in your portfolio sometimes.
And that's what we're looking at today.
• Price less than or equal to $10
• Average Dollar Volume greater than or equal to $1,000,000
(Price x volume shows you how much money is trading in and out of the stock on a daily basis.)
• Weekly Volume greater than Previous Week's Volume (any two out of three weeks)
(Want to see increasing volume to show greater investor interest and demand.)
• Zacks Rank less than or equal to 3
(No Sells or Strong Sells.)
• Average Broker Rating less than or equal to 3.5
(Average Broker Rating of a Hold or Better.)
• # of Analysts in Rating greater than or equal to 2
(Minimum of at least two analysts covering the stock.)
• % Change F1 Earnings Estimate Revisions -- 12 Weeks greater than or equal to 0
(Preferably upward earnings estimate revisions, but definitely no downward revisions.)
Here are 5 stocks that made it through this week's screen:
(NASDAQ:GLUU – Free Report) Glu Mobile
(NASDAQ:CLMT – Free Report) Calumet Specialty Products Partners
(NASDAQ:TBBK – Free Report) The Bancorp
(NASDAQ:IMMU – Free Report) Immunomedics
(NYSE:HBM – Free Report) Hudbay Minerals
I think each one of these picks has big potential. And the entire list is worth a thorough analysis.
I would not suggest filling up an entire portfolio of stocks under $10 though. But adding a careful selection of some of the best cheap stock names could add some excess returns to your bottom line, not to mention a little excitement to your stock picking process as well.
Get the rest of the stocks on this list and start screening for the best stocks under $10 for yourself. And don't forget to backtest your strategy so you'll know how successful it's been before you put any of your money at risk. You can do it.
Sign up for a free two week trial to the Research Wizard today.
About Screen of the Week
Zacks.com created the first and best screening system on the web earning the distinction as the "#1 site for screening stocks" by Money Magazine. But powerful screening tools is just the start. That is why Zacks created the Screen of the Week to highlight profitable stock picking strategies that investors can actively use. Each week, Zacks Profit from the Pros free email newsletter shares a new screening strategy. Learn more about it here https://at.zacks.com/?id=112
Zacks.com is a property of Zacks Investment Research, Inc., which was formed in 1978. The later formation of the Zacks Rank, a proprietary stock picking system; continues to outperform the market by nearly a 3 to 1 margin. The best way to unlock the profitable stock recommendations and market insights of Zacks Investment Research is through our free daily email newsletter; Profit from the Pros. In short, it's your steady flow of Profitable ideas GUARANTEED to be worth your time!Click here for your free subscription to Profit from the Pros.
Get the full Report on GLUU - FREE
Get the full Report on CLMT - FREE
Get the full Report on TBBK - FREE
Get the full Report on IMMU - FREE
Get the full Report on HBM - FREE
Follow us on Twitter: https://twitter.com/zacksresearch
Join us on Facebook: https://www.facebook.com/ZacksInvestmentResearch
Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.
Contact: Jim Giaquinto
Zacks.com provides investment resources and informs you of these resources, which you may choose to use in making your own investment decisions. Zacks is providing information on this resource to you subject to the Zacks "Terms and Conditions of Service" disclaimer. www.zacks.com/disclaimer.
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss.This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performancefor information about the performance numbers displayed in this press release.